Platelets and coronary heart disease: therapy update.
D001161:Arteriosclerosis / Q000097:blood; D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use*; D011464:Epoprostenol / Q000096:biosynthesis; D006487:Hemostasis; D006801:Humans; D011433:Propranolol / Q000627:therapeutic use*; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D012306:Risk; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013928:Thromboxane A2 / Q000096:biosynthesis
D011448:Prostaglandin Antagonists; D013928:Thromboxane A2; D004176:Dipyridamole; D011433:Propranolol; D011464:Epoprostenol; D001241:Aspirin; D013442:Sulfinpyrazone